The use of artificial intelligence in patent ductus arteriosus diagnosis and treatment: a systematic scoping review
Background. Background and objectives: Patent ductus arteriosus (PDA) is a common congenital cardiac condition, especially in premature infants, and is associated with significant morbidity and mortality. Artificial intelligence (AI) has emerged as a promising tool to aid clinicians in diagnosing PDA and guiding treatment decisions amidst this uncertainty. Methods. A literature search (up to December 2025) was conducted in PubMed, Scopus, and Web of Science for peer-reviewed studies on AI (including machine lear…

In brief
A systematic scoping review searched PubMed, Scopus, and Web of Science through December 2025 and identified seventeen studies applying AI to patent ductus arteriosus, mostly in preterm neonates. The tools focused on diagnosing the condition and predicting outcomes from clinical and echocardiographic data.
The findings matter because PDA is a common congenital heart condition tied to serious illness and death in premature infants, so earlier and more consistent decisions could help. Still, the authors' hopes for reduced variability and better outcomes are projections, and the reviewed evidence lacked external validation and data transparency.
Main points
- Seventeen studies met inclusion criteria, predominantly involving preterm neonates.
- AI work mainly targeted PDA diagnosis and outcome prediction using clinical and echocardiographic data.
- Imaging-based deep learning generally beat tabular-data models, with AUC often above 0.80.
- Overall study quality was rated moderate.
- Authors suggest PDA could serve as a model for broader medical AI use.
The gain
Imaging-based deep learning models for patent ductus arteriosus diagnosis and outcome prediction in preterm neonates often reached an AUC above 0.80, outperforming approaches using tabular data.
The rundown
The review covered peer-reviewed studies of machine learning, deep learning, computer vision, and predictive analytics applied to PDA, searching three major databases up to December 2025.
Results showed that models using echocardiographic images tended to perform better than those built on tabular clinical data, though the review reports performance only in general terms.
The conclusions that AI could enable earlier detection, more consistent decisions, and individualized treatment planning are stated as potential benefits rather than measured clinical outcomes.
Sources
- Peer-reviewedThe Turkish Journal of Pediatrics2026-10-21
ace
The debate